1. Home
  2. MS vs AZN Comparison

MS vs AZN Comparison

Compare MS & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morgan Stanley

MS

Morgan Stanley

HOLD

Current Price

$165.91

Market Cap

255.2B

Sector

Finance

ML Signal

HOLD

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

HOLD

Current Price

$203.14

Market Cap

311.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MS
AZN
Founded
1924
1992
Country
United States
United Kingdom
Employees
83000
96100
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
255.2B
311.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MS
AZN
Price
$165.91
$203.14
Analyst Decision
Buy
Strong Buy
Analyst Count
15
1
Target Price
$178.00
N/A
AVG Volume (30 Days)
5.6M
1.7M
Earning Date
04-15-2026
04-28-2026
Dividend Yield
2.41%
1.59%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.09
$10.13
Revenue Next Year
$5.39
$6.21
P/E Ratio
$17.30
$31.91
Revenue Growth
N/A
N/A
52 Week Low
$94.33
$61.24
52 Week High
$192.68
$212.71

Technical Indicators

Market Signals
Indicator
MS
AZN
Relative Strength Index (RSI) 51.99 66.95
Support Level $154.82 $182.39
Resistance Level $165.96 $211.32
Average True Range (ATR) 4.59 3.50
MACD 1.19 0.28
Stochastic Oscillator 73.93 92.48

Price Performance

Historical Comparison
MS
AZN

About MS Morgan Stanley

Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $9.3 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with more than $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Share on Social Networks: